Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Lade...
Vorschaubild
Dateien
Offensperger_2-12mdr75ce5vkv3.pdf
Offensperger_2-12mdr75ce5vkv3.pdfGröße: 576.86 KBDownloads: 33
Datum
2020
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Cell chemical biology. Cell Press. 2020, 27(12), pp. 1510-1520.e6. ISSN 2451-9456. eISSN 2451-9448. Available under: doi: 10.1016/j.chembiol.2020.08.017
Zusammenfassung

Genetic aberrations of the UBE3A gene encoding the E3 ubiquitin ligase E6AP underlie the development of Angelman syndrome (AS). Approximately 10% of AS individuals harbor UBE3A genes with point mutations, frequently resulting in the expression of full-length E6AP variants with defective E3 activity. Since E6AP exists in two states, an inactive and an active one, we hypothesized that distinct small molecules can stabilize the active state and that such molecules may rescue the E3 activity of AS-derived E6AP variants. Therefore, we established an assay that allows identifying modulators of E6AP in a high-throughput format. We identified several compounds that not only stimulate wild-type E6AP but also rescue the E3 activity of certain E6AP variants. Moreover, by chemical cross-linking coupled to mass spectrometry we provide evidence that the compounds stabilize an active conformation of E6AP. Thus, these compounds represent potential lead structures for the design of drugs for AS treatment.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
570 Biowissenschaften, Biologie
Schlagwörter
Angelman syndrome; E6AP; UBE3A ; ubiquitin ligase; fluorescence polarization; high-throughput screen; small-molecule activator; cross-linking coupled to mass spectrometry; XL-MS
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690OFFENSPERGER, Fabian, Franziska MÜLLER, Jasmin JANSEN, Daniel HAMMLER, Kathrin H. GÖTZ, Andreas MARX, Carissa L. SIROIS, Stormy J. CHAMBERLAIN, Florian STENGEL, Martin SCHEFFNER, 2020. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants. In: Cell chemical biology. Cell Press. 2020, 27(12), pp. 1510-1520.e6. ISSN 2451-9456. eISSN 2451-9448. Available under: doi: 10.1016/j.chembiol.2020.08.017
BibTex
@article{Offensperger2020-12-17Ident-51153,
  year={2020},
  doi={10.1016/j.chembiol.2020.08.017},
  title={Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants},
  number={12},
  volume={27},
  issn={2451-9456},
  journal={Cell chemical biology},
  pages={1510--1520.e6},
  author={Offensperger, Fabian and Müller, Franziska and Jansen, Jasmin and Hammler, Daniel and Götz, Kathrin H. and Marx, Andreas and Sirois, Carissa L. and Chamberlain, Stormy J. and Stengel, Florian and Scheffner, Martin}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/51153">
    <dc:contributor>Jansen, Jasmin</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/51153"/>
    <dc:language>eng</dc:language>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:issued>2020-12-17</dcterms:issued>
    <dc:contributor>Müller, Franziska</dc:contributor>
    <dc:contributor>Marx, Andreas</dc:contributor>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51153/1/Offensperger_2-12mdr75ce5vkv3.pdf"/>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:creator>Offensperger, Fabian</dc:creator>
    <dc:contributor>Stengel, Florian</dc:contributor>
    <dcterms:title>Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants</dcterms:title>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Sirois, Carissa L.</dc:creator>
    <dcterms:abstract xml:lang="eng">Genetic aberrations of the UBE3A gene encoding the E3 ubiquitin ligase E6AP underlie the development of Angelman syndrome (AS). Approximately 10% of AS individuals harbor UBE3A genes with point mutations, frequently resulting in the expression of full-length E6AP variants with defective E3 activity. Since E6AP exists in two states, an inactive and an active one, we hypothesized that distinct small molecules can stabilize the active state and that such molecules may rescue the E3 activity of AS-derived E6AP variants. Therefore, we established an assay that allows identifying modulators of E6AP in a high-throughput format. We identified several compounds that not only stimulate wild-type E6AP but also rescue the E3 activity of certain E6AP variants. Moreover, by chemical cross-linking coupled to mass spectrometry we provide evidence that the compounds stabilize an active conformation of E6AP. Thus, these compounds represent potential lead structures for the design of drugs for AS treatment.</dcterms:abstract>
    <dc:creator>Chamberlain, Stormy J.</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/51153/1/Offensperger_2-12mdr75ce5vkv3.pdf"/>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:contributor>Hammler, Daniel</dc:contributor>
    <dc:creator>Jansen, Jasmin</dc:creator>
    <dc:contributor>Sirois, Carissa L.</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-01T09:51:11Z</dc:date>
    <dc:contributor>Scheffner, Martin</dc:contributor>
    <dc:contributor>Offensperger, Fabian</dc:contributor>
    <dc:contributor>Götz, Kathrin H.</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:creator>Scheffner, Martin</dc:creator>
    <dc:creator>Götz, Kathrin H.</dc:creator>
    <dc:creator>Marx, Andreas</dc:creator>
    <dc:creator>Stengel, Florian</dc:creator>
    <dc:contributor>Chamberlain, Stormy J.</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2020-10-01T09:51:11Z</dcterms:available>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:creator>Müller, Franziska</dc:creator>
    <dc:creator>Hammler, Daniel</dc:creator>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Ja
Diese Publikation teilen